WallStreetZenWallStreetZen

NYSE: SNN
Smith & Nephew PLC Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Smith & Nephew earnings were $412.0M for the trailing 12 months ending Dec 31, 2024, with 56.3% growth year over year. The latest SNN earnings report on Dec 31, 2024 announced Q4 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SNN reported annual earnings of $412.0M, with 56.7% growth. The next SNN earnings date is May 1, 2025.

SNN past earnings growth

How has SNN's earnings growth performed historically?

Company
56.29%
Industry
48.25%
Market
63.03%
SNN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
SNN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
SNN's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

SNN earnings history

Current Revenue
$5.8B
Current Earnings
$412.0M
Current Profit Margin
7.1%
SNN's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

SNN Return on Equity

Current Company
7.9%
Current Industry
11.5%
Current Market
34.1%
SNN's Return on Equity (7.9%)... subscribe to Premium to read more.
High Return on Equity Performance

SNN undefined

Current Company
4.1%
Current Industry
8%
SNN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SNN announces earnings.

SNN undefined

Current Company
7.29%
Current Industry
9%
SNN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SNN vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SNN$1.29B$412.00M-7.21%$0.94
PEN$44.57M$14.01M-23.68%$0.36
ALGN$792.43M$421.36M+0.21%$5.63
GMED$378.94M$102.98M-13.51%$0.76
MASI-$202.30M-$304.90MN/A-$5.72
View Top Medical Device Stocks

SNN earnings dates

Next earnings date
May 1, 2025

Smith & Nephew Earnings Reports & History FAQ

What were Smith & Nephew's earnings last quarter?

On SNN's earnings call on Invalid Date, Smith & Nephew (NYSE: SNN) reported Q4 2024 earnings per share (EPS) of N/A, up N/A year over year. Total SNN earnings for the quarter were N/A. In the same quarter last year, Smith & Nephew's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Smith & Nephew stock.

When does Smith & Nephew report earnings?

The next SNN earnings call is Invalid Date. Add SNN to your watchlist to be reminded of Smith & Nephew's next earnings date.

What was SNN's earnings growth in the past year?

As of Smith & Nephew's earnings date in Invalid Date, Smith & Nephew's earnings has grown 56.29% year over year. This is 8.04 percentage points higher than the US Medical Devices industry earnings growth rate of 48.25%. SNN earnings in the past year totalled $412.00 million.

Is Smith & Nephew profitable or losing money?

As of the last Smith & Nephew earnings report, Smith & Nephew is currently profitable. Smith & Nephew's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $412.00 million, a 56.65% increase year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.